Press release
Complicated Urinary Tract Infection Market Size was USD ~1,800 Million in 2021, estimates DelveInsight
Complicated Urinary Tract Infection Market
The Complicated Urinary Tract Infection market report provides current treatment practices, emerging complicated urinary tract infection drugs, market share of the individual therapies, current and forecasted complicated urinary tract infection market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current complicated urinary tract infection treatment practice/algorithm, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Key Takeaways from the Complicated Urinary Tract Infection Market Report
• In the year 2021, the total Complicated Urinary Tract Infection diagnosed incident cases were 8.08 Million in the 7MM which are expected to grow during the study period, i.e., 2019-2032.
• The highest number of total Complicated Urinary Tract Infection incident cases was observed in Germany among the EU5 countries with 0.87 M cases in 2021 which are expected to grow during the study period, i.e., 2019-2032.
• The leading Complicated Urinary Tract Infection Companies are working in the market include Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, and others
• Emerging Complicated Urinary Tract Infection Pipeline Therapies in the various stages of development include Ceftazidime -avibactam, Cefepime-zidebactam (FEP-ZID), Meropenem, Doripenem, Eravacycline, Levofloxacin, CXA-101, Ceftazidime, Benapenem, Ertapenem, TBPM-PI-HBr, Ertapenem, Imipenem+Cilastatin/Relebactam, and others
• On June, 2023, Meiji Seika Pharma Co., Ltd announced a drug name is imipenem/cilastatin with phase 3. Phase 3 study to evaluate the efficacy and safety of cefepime/nacubactam or aztreonam/nacubactam compared to imipenem/cilastatin in the treatment of complicated urinary tract infections (cUTI) or acute uncomplicated pyelonephritis (AP).
• On May, 2023, Wockhardt announced a drug name is Cefepime-zidebactam (FEP-ZID) with phase 3. This is a Phase 3, randomized, double-blind, multicenter, non-inferiority study to evaluate the efficacy, safety, and tolerability of FEP-ZID vs. meropenem in the treatment of hospitalized adults with cUTI or AP.
Discover more about therapies set to grab major Complicated Urinary Tract Infection Market Share @ Complicated Urinary Tract Infection Market Outlook- https://www.delveinsight.com/report-store/complicated-urinary-tract-infections-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Complicated Urinary Tract Infection Overview
Urinary tract infections (UTIs) are amongst the most frequent bacterial infections. They can manifest clinically in various ways, from relatively benign, uncomplicated infections to complicated UTIs (cUTIs), pyelonephritis, and severe urosepsis. cUTI is a heterogeneous entity comprising multiple forms.
Complicated Urinary Tract Infection Epidemiology Segmentation in the 2032
• Total Complicated Urinary Tract Infection Occurrence-specific Cases
• Total Complicated Urinary Tract Infection Pathogen-specific Cases
• Total Complicated Urinary Tract Infection Diagnosed Cases
• Total Complicated Urinary Tract Infection Age-specific Cases
• Total Complicated Urinary Tract Infection Treated Cases
Download the report to understand which factors are driving Complicated Urinary Tract Infection Epidemiology Trends @ Complicated Urinary Tract Infection Epidemiological Insights- https://www.delveinsight.com/sample-request/complicated-urinary-tract-infections-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Complicated Urinary Tract Infection Emerging Drugs
• Tebipenem Pivoxil Hydrobromide: Spero Therapeutics
Spero Therapeutics is developing tebipenem HBr (tebipenem pivoxil hydrobromide; formerly SPR994) as an oral antibiotic for the treatment of complicated urinary tract infection (cUTI) and acute pyelonephritis (AP) to help patients avoid hospitalizations (stay at home) and/or transition patients home after IV therapy (get home).
• Sulopenem: Iterum Therapeutics
Sulopenem is an orally bioavailable, broad-spectrum penem β-lactam antibiotic which is being developed for the treatment of infections caused by multi-drug resistant bacteria. Sulopenem was discovered in the laboratories of Pfizer Inc. in the 1980s and was first developed with an intravenous (IV) formulation only. The company completed an extensive pre-clinical program, followed by human studies. Later, an oral formulation was developed and tested in Phase I and Phase II trials.
Complicated Urinary Tract Infection Treatment Market
The main course of treatment for individuals with lower UTIs is an oral medication with an empirically selected antibiotic that is effective against Gram-negative aerobic coliform bacteria, such as Escherichia coli. Currently, there are several types of medications used for treatment purposes, namely beta-lactamase inhibitors, protein synthesis inhibitors, and others. First-line antibiotics should be used to begin empiric therapy in this circumstance. Before initiating therapy, a urine sample should be sent for microscopy and culture. Severe Complicated Urinary Tract Infection can present as severe undifferentiated sepsis or even septic shock. Pharmacotherapy aims to eradicate the infection, prevent complications, and provide symptomatic relief to patients. Early treatment is recommended to reduce the risk of progression to pyelonephritis.
To know more about Complicated Urinary Tract Infection Treatment options, visit @ Complicated Urinary Tract Infection Drugs- https://www.delveinsight.com/sample-request/complicated-urinary-tract-infections-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Complicated Urinary Tract Infection Market Dynamics
The complicated urinary tract infection market dynamics is anticipated to change in the coming years owing to the improvement in the rise in number of healthcare spending across the world and rising cases of uncomplicated urinary tract infection. Key players, such as, Allecra Therapeutics, Venatorx Pharmaceuticals, Wockhardt, Spero Therapeutics etc are involved in developing drugs for Complicated Urinary Tract Infection.
Complicated Urinary Tract Infection Market Insights
Urinary Tract Infection affects any part of the urinary system, including kidneys, bladder, ureters, and urethra, has been categorized into uncomplicated and complicated urinary tract infection. Frequent sexual intercourse is one of the biggest urinary tract infection risk factors for younger women. Short-term goals are to ameliorate symptoms and prevent complications, including sepsis and death or other potential manifestations such as impaired diabetic control.
Learn more about the Complicated Urinary Tract Infection Pipeline Therapies in clinical trials @ Complicated Urinary Tract Infection Market Landscape- https://www.delveinsight.com/sample-request/complicated-urinary-tract-infections-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Complicated Urinary Tract Infection Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• Complicated Urinary Tract Infection Companies- Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, and others
• Complicated Urinary Tract Infection Pipeline Therapies-Ceftazidime -avibactam, Cefepime-zidebactam (FEP-ZID), Meropenem, Doripenem, Eravacycline, Levofloxacin, CXA-101, Ceftazidime, Benapenem, Ertapenem, TBPM-PI-HBr, Ertapenem, Imipenem+Cilastatin/Relebactam, and others
• Complicated Urinary Tract Infection Market Dynamics: Complicated Urinary Tract Infection Market Drivers and Barriers
• Complicated Urinary Tract Infection Market Access and Reimbursement
Discover more about Complicated Urinary Tract Infection Drugs in development @ Complicated Urinary Tract Infection Ongoing Clinical Trials Analysis- https://www.delveinsight.com/sample-request/complicated-urinary-tract-infections-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Complicated Urinary Tract Infection Report Introduction
3. Table of Contents
4. Complicated Urinary Tract Infection Market Overview at a Glance
5. Executive Summary of Complicated Urinary Tract Infection
6. Key Events
7. Complicated Urinary Tract Infection Epidemiology and Market Methodology
8. Disease Background and Overview
9. Complicated Urinary Tract Infection Treatment and Management
10. Epidemiology and Patient Population
11. Patient Journey
12. Complicated Urinary Tract Infection Marketed Drugs
13. Key Endpoints in Complicated Urinary Tract Infection Clinical Trials
14. Complicated Urinary Tract Infection Emerging Drugs
15. Conjoint Analysis
16. Complicated Urinary Tract Infection: Seven Major Market Analysis
17. Complicated Urinary Tract Infection Market Access and Reimbursement
18. KOL Views
19. Complicated Urinary Tract Infection SWOT Analysis
20. Complicated Urinary Tract Infection Unmet Needs
21. Appendix
22. DelveInsight Capabilities
23. Disclaimer
24. About DelveInsight
Get in touch with our Business executive @ Complicated Urinary Tract Infection Market Drivers and Barriers- https://www.delveinsight.com/sample-request/complicated-urinary-tract-infections-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Important Published Links-
https://treadmill.mn.co/posts/45459156
https://chineseintheus.mn.co/posts/parkinsons-disease-market-size-outlook-and-forecast
https://wear.net/dennydones9/
https://productinn.mn.co/posts/parkinsons-disease-market-outlook-and-forecast-report-2032
https://justchatting.mn.co/posts/45460636
https://expressyourcurve.mn.co/posts/45460860
https://clinalleve.mn.co/posts/parkinsons-disease-market-size-outlook-and-forecast-2032
https://nhattao.com/members/user6331540.6331540/
https://seedly.sg/profile/denny-dones/
https://note.com/denny_dones/n/n489e5dd1ff1a
https://www.storeboard.com/JohnSmith-5965202
https://doodleordie.com/profile/dennydones99
https://macro.market/company/delveinsight-business-research
https://pantip.com/profile/7306022#topics
https://allmylinks.com/dennydonesusa
https://uconnect.ae/read-blog/4382
https://blacksnetwork.net/post/102497_herpetic-keratitis-is-a-condition-that-affects-the-eye-and-is-caused-by-the-herp.html
https://ekonty.com/-dennydones99
https://app.wedonthavetime.org/posts/03e285b9-e449-4c96-b257-8cb7a2b74243
https://www.weddingbee.com/members/dennydones99/
https://community.storytellingwithdata.com/members/me/gallery
https://participer.valdemarne.fr/profiles/denny_dones/activity
https://elderassociation.mn.co/posts/45117025
https://www.domestika.org/en/dennydones99
https://nxgen.mn.co/members/19995548
https://www.laclt.com/profile/ybhardwaj/profile
https://stemfemmes.mn.co/posts/emerging-trends-in-managing-hot-flashes-in-the-prostate-cancer-market
https://network-91053.mn.co/posts/45119865
https://autism-support.mn.co/posts/understanding-hot-flashes-in-prostate-cancer-market-size-and-outlook-2032
https://jasa-seo.mn.co/posts/45120226
https://lapp.unl.edu.ec/profiles/dennydones99/activity?locale=en
https://imarticus.org/skillenza/user/dennydones9
https://oppathingzz.mn.co/members/20019648
https://findaspring.org/members/dennydones9/
https://www.poeticous.com/yashveer-bhardwaj
https://git.disroot.org/dennydones9
https://kuula.co/profile/havensmith
https://artmight.com/user/profile/3082810
https://www.credly.com/users/denny-dones/badges
https://quantum-buoyancy.mn.co/posts/axillary-hyperhidrosis-market-size-and-outlook-delveinsight
https://freeline.mn.co/posts/45202136
https://3dwarehouse.sketchup.com/user/0e9f9584-794e-4467-ac59-79db9efbadd9/Denny-Dones
https://www.hackster.io/dennydones9
https://letterboxd.com/dennydones9/
https://ko-fi.com/dennydones9
https://wakelet.com/@DennyDones813
https://onedio.com/profil/dennydones9
https://www.lyrics.com/user/349564/dennydones9#google_vignette
https://hypothes.is/users/dennydones9
https://shivambhu-hut.mn.co/posts/exploring-the-axillary-hyperhidrosis-market-innovations-treatments-and-future-prospects
https://zumvu.com/dennydones9/
https://onlyfans.com/dennydones9
https://maker.wiznet.io/dennydones9
https://collab.sundance.org/people/Denny-Dones-1699939772
https://insurtechasia.mn.co/posts/45403575
https://meganto-lottery.mn.co/posts/45403650
https://ylimun.mn.co/posts/45403740
https://network-79379.mn.co/posts/45404061
https://acatpg.mn.co/posts/45404422
https://brooklynneo.mn.co/posts/45404495
https://ucat-bootcamp.mn.co/posts/45404540
https://coding-playground.mn.co/posts/45404600
https://living-word-network.mn.co/posts/45404653
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers and acquisitions.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Complicated Urinary Tract Infection Market Size was USD ~1,800 Million in 2021, estimates DelveInsight here
News-ID: 3289182 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Urinary
Emerging Urinary Incontinence Market Trend 2025-2034: Pioneering Patient Care Wi …
How Is the Urinary Incontinence Market Projected to Grow, and What Is Its Market Size?
The market for urinary incontinence has witnessed significant expansion in the recent past. It is forecasted to progress from a valuation of $12.52 billion in 2024 to an estimated worth of $13.37 billion in 2025, predicting a Compound Annual Growth Rate (CAGR) of 6.8%. Factors that contributed to this growth during the historical period include a…
Urinary Drainage Bags Market Is Driven By Urinary Drainage Bags In Various Indus …
The Urinary Drainage Bags Market has experienced substantial growth in recent years, driven by a combination of factors, including the increasing elderly population, a higher prevalence of urinary incontinence, and a growing emphasis on patient care and comfort. Urinary drainage bags are essential medical devices used for the collection and management of urine in individuals with various medical conditions, such as those recovering from surgery, dealing with urinary retention, or…
Urinary Catheters Market - Urinary Catheters: Innovations Transforming Comfort a …
Newark, New Castle, USA: The "Urinary Catheters Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Urinary Catheters Market: https://www.growthplusreports.com/report/urinary-catheters-market/8720
This latest report researches the industry structure, sales, revenue,…
Urinary Stents Market - Unleash the Power of Urinary Stents: Elevate Your Urolog …
Newark, New Castle, USA: The "Urinary Stents Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Urinary Stents Market: https://www.growthplusreports.com/report/urinary-stents-market/8681
This latest report researches the industry structure, sales, revenue,…
Urinary Catheters Market: The ins and Outs of Urinary Catheters with Region Wise …
Allied Market Research recently said Urinary catheters are a medical device used to drain urine from the bladder when a patient is unable to do so on their own. They are commonly used in hospitals and long-term care facilities, as well as for individuals with certain medical conditions. Urinary catheters come in a variety of types, including indwelling catheters, which remain in the bladder for an extended period of time,…
Urinary Incontinence Market: New research activities show links between urinary …
The prevalence of urinary incontinence has affected a majority of population and the possibility of this condition increases with age. Majority of old adults and women have been facing the issue and availing treatments to improve quality of lives. Research activities found the connection between urinary incontinence and other health conditions such as mental health and falls. After conducting different research activities, new findings have emerged. Researchers suggested doctors to…
